跳至主要内容
临床试验/JPRN-UMIN000016952
JPRN-UMIN000016952已完成未知

Evaluation of intraindividual variability in hepatic CYP3A4 enzyme activity using endogenous markers in lung cancer patients treated with chemotherapeutic drugs and aprepitant - Evaluation of intraindividual variability in hepatic CYP3A4 enzyme activity using endogenous markers in lung cancer patients treated with chemotherapeutic drugs and aprepitant

Keio University Faculty of Pharmacy0 个研究点目标入组 60 人开始时间: 2015年3月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients who required other chemotherapy 2)Patients who qre actively receiving inducer or inhibitor of CYP3A4 3)Patients who qre actively receiving androgen or estrogen preparation 4)Patients who qre actively receiving adrenal cortex hormone preparation without dexamethasone 5)Patients who qre actively receiving blood transfusion

研究者

发起方
Keio University Faculty of Pharmacy

相似试验